转移性激素敏感性前列腺癌研究进展(4)
[13]James ND，Spears MR，Sydes MR.Abiraterone in Metastatic Prostate Cancer[J].N Engl J Med，2017，377(17)：1696-1697.[14]Rydzewska L，Burdett S，Vale CL，et al.Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer：A systematic review and meta-analysis[J].Eur J Cancer ......
您现在查看是摘要页，全文长 2610 字符。